Drugs / BT097
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 3 | NCT05170269 | Nov 2021 → Nov 2023 | cytomegalovirus infection | Biotest | Terminated | No outcome recorded Stop: Business |
Evidence & citations 2 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | BT097 | ClinicalTrials.gov intervention name — accepted as the source's own label NCT05170269 ↗ |
| Route | Intravenous | “intravenously” NCT05170269 ↗ |